Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Batten-1 in Pediatric Subjects With CLN3 Disease
NCT07882290Phase 3Not yet recruiting
- Sponsor
- Beyond Batten Disease Foundation
- Start
- Dec 2026
- Primary completion
- Jun 2028
- Countries
- 8
01
Overview
A Phase 3 trial of miglustat in CLN3 disease (CLN3), sponsored by Beyond Batten Disease Foundation. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
miglustat
03
Conditions
CLN3 disease (CLN3)
Beyond the preview
Go deeper on NCT07882290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07882290.